Cubic Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $4.4M | Buy |
158,412
+4,639
| +3% | +$129K | 1.04% | 28 |
|
|
2023
Q4 | $4.43M | Buy |
153,773
+6,448
| +4% | +$195K | 1.14% | 25 |
|
|
2023
Q3 | $4.89M | Sell |
147,325
-8,927
| -6% | -$316K | 1.34% | 22 |
|
|
2023
Q2 | $5.73M | Buy |
156,252
+1,310
| +0.8% | +$51K | 1.54% | 21 |
|
|
2023
Q1 | $6.32M | Buy |
154,942
+388
| +0.3% | +$16.8K | 1.77% | 18 |
|
|
2022
Q4 | $7.92M | Sell |
154,554
-8,412
| -5% | -$403K | 2.26% | 6 |
|
|
2022
Q3 | $7.13M | Sell |
162,966
-440
| -0.3% | -$21.4K | 2.12% | 9 |
|
|
2022
Q2 | $8.57M | Sell |
163,406
-2,292
| -1% | -$117K | 2.31% | 5 |
|
|
2022
Q1 | $8.58M | Sell |
165,698
-25
| -0% | -$1.3K | 2% | 7 |
|
|
2021
Q4 | $9.79M | Buy |
165,723
+315
| +0.2% | +$15.6K | 2.22% | 5 |
|
|
2021
Q3 | $7.11M | Sell |
165,408
-430
| -0.3% | -$19K | 1.76% | 11 |
|
|
2021
Q2 | $6.49M | Sell |
165,838
-481
| -0.3% | -$18.7K | 1.6% | 17 |
|
|
2021
Q1 | $6.03M | Sell |
166,319
-2,241
| -1% | -$79.6K | 1.59% | 17 |
|
|
2020
Q4 | $6.21M | Sell |
168,560
-8,215
| -5% | -$301K | 1.84% | 13 |
|
|
2020
Q3 | $6.16M | Sell |
176,775
-801
| -0.5% | -$28.1K | 2.21% | 10 |
|
|
2020
Q2 | $5.51M | Buy |
177,576
+744
| +0.4% | +$25.3K | 1.97% | 11 |
|
|
2020
Q1 | $5.48M | Sell |
176,832
-3,768
| -2% | -$128K | 2.21% | 8 |
|
|
2019
Q4 | $6.71M | Buy |
180,600
+6,932
| +4% | +$247K | 1.89% | 12 |
|
|
2019
Q3 | $5.92M | Buy |
173,668
+3,567
| +2% | +$130K | 1.77% | 16 |
|
|
2019
Q2 | $6.99M | Sell |
170,101
-4,792
| -3% | -$190K | 2.1% | 7 |
|
|
2019
Q1 | $7.05M | Sell |
174,893
-307
| -0.2% | -$12.3K | 2.08% | 5 |
|
|
2018
Q4 | $7.26M | Buy |
175,200
+616
| +0.4% | +$25.6K | 2.37% | 3 |
|
|
2018
Q3 | $7.3M | Buy |
174,584
+264
| +0.2% | +$10.2K | 2% | 6 |
|
|
2018
Q2 | $6M | Sell |
174,320
-5,780
| -3% | -$198K | 1.73% | 15 |
|
|
2018
Q1 | $6.06M | Buy |
180,100
+435
| +0.2% | +$15K | 1.71% | 15 |
|
|
2017
Q4 | $6.17M | Sell |
179,665
-4,763
| -3% | -$162K | 1.72% | 14 |
|
|
2017
Q3 | $6.25M | Sell |
184,428
-319
| -0.2% | -$10.3K | 1.76% | 12 |
|
|
2017
Q2 | $5.89M | Buy |
184,747
+1,070
| +0.6% | +$33.7K | 1.72% | 13 |
|
|
2017
Q1 | $5.96M | Buy |
183,677
+1,454
| +0.8% | +$45.8K | 1.81% | 12 |
|
|
2016
Q4 | $5.62M | Buy |
182,223
+13,576
| +8% | +$414K | 1.73% | 14 |
|
|
2016
Q3 | $5.42M | Buy |
168,647
+3,304
| +2% | +$110K | 1.75% | 14 |
|
|
2016
Q2 | $5.52M | Sell |
165,343
-90
| -0.1% | -$2.87K | 1.88% | 10 |
|
|
2016
Q1 | $4.65M | Buy |
165,433
+245
| +0.1% | +$7K | 1.56% | 16 |
|
|
2015
Q4 | $5.06M | Buy |
165,188
+269
| +0.2% | +$8.46K | 1.75% | 13 |
|
|
2015
Q3 | $4.92M | Buy |
164,919
+31
| +0% | +$994 | 1.74% | 11 |
|
|
2015
Q2 | $5.25M | Sell |
164,888
-3,856
| -2% | -$126K | 1.67% | 15 |
|
|
2015
Q1 | $5.57M | Buy |
168,744
+8,874
| +6% | +$282K | 1.79% | 9 |
|
|
2014
Q4 | $4.72M | Buy |
159,870
+3,579
| +2% | +$103K | 1.52% | 24 |
|
|
2014
Q3 | $4.38M | Buy |
156,291
+4,382
| +3% | +$123K | 1.54% | 22 |
|
|
2014
Q2 | $4.28M | Buy |
151,909
+4,237
| +3% | +$121K | 1.41% | 24 |
|
|
2014
Q1 | $4.5M | Buy |
147,672
+717
| +0.5% | +$21.4K | 1.55% | 19 |
|
|
2013
Q4 | $4.27M | Sell |
146,955
-2,103
| -1% | -$61.2K | 1.34% | 22 |
|
|
2013
Q3 | $4.06M | Sell |
149,058
-658
| -0.4% | -$17.9K | 1.32% | 22 |
|
|
2013
Q2 | $3.98M | Buy |
+149,716
| New | +$4.14M | 1.37% | 23 |
|
Other funds holding PFE
Cubic Asset Management's PFE Position: Q1 2024 in Review
Cubic Asset Management increased its Pfizer (PFE) stake by 3% in Q1 2024, buying an estimated $129K and bringing the position to 158,412 shares worth $4.4M. The position accounts for 1.04% of the portfolio, ranked #28.
Cubic Asset Management first reported a position in PFE in Q2 2013 and has held it in 44 quarters since. The position peaked at $9.79M in Q4 2021. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Cubic Asset Management held 158,412 shares of Pfizer worth $4.4M as of Q1 2024.
- Cubic Asset Management bought 4,639 Pfizer shares in Q1 2024, an estimated $129K.
- Pfizer made up 1.04% of Cubic Asset Management's portfolio in Q1 2024, its #28 holding.
- Cubic Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 44 quarters since.
- Cubic Asset Management's Pfizer position peaked at $9.79M in Q4 2021.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Cubic Asset Management's 13F filing for Q1 2024, filed 24 Apr 2024.